Prescription drug payment reform. Pharmaceutical supply chain.
2025 · 4th Quarter (Oct 1 - Dec 31)
REGENXBIO INC.
Filed by LMH STRATEGIC SOLUTIONS.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 12, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- LMH STRATEGIC SOLUTIONS
- Client
- REGENXBIO INC.
- Filing UUID
- 242d5db5-fceb-4893-b92c-197974c6aada
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
General Medicare and Medicaid Issues.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.